← Back
Data updated: Mar 10, 2026
CONCORD BIOTECH LTD
Neurology
CONCORD BIOTECH LTD is a generic drug manufacturer focused on Neurology.
2019
Since
4
Drugs
-
Trials
114
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
MYCOPHENOLATE MOFETIL 2026-02-23
Labeling
MYCOPHENOLATE MOFETIL 2026-01-14
Labeling
MYCOPHENOLATE MOFETIL 2026-01-14
Labeling
MYCOPHENOLATE SODIUM 2026-01-14
Labeling
TACROLIMUS 2025-10-17
Labeling
TACROLIMUS 2025-10-17
Labeling
TACROLIMUS 2025-10-17
Labeling
TACROLIMUS 2025-10-17
Labeling
TACROLIMUS 2025-09-26
Labeling
TACROLIMUS 2025-09-26
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (3)
Discontinued (1)
Company Info
- First Approval
- 2019-01-08
- Latest
- 2025-04-07
- Applications
- 5